Big effect

In a 73-child trial, store-bought peanut butter desensitized 100% of high-threshold allergic kids — versus 21% with avoidance, though the result applies only to this narrow clinical group.

This is a striking proof-of-concept for mild peanut allergies, but it’s a single small trial in children already able to tolerate some peanut — not a green light for anyone else to try home dosing.

Researchers tested a supervised, gradual peanut butter regimen in children with high-threshold peanut allergy, meaning they could already handle small amounts without severe reaction. The treatment group achieved a 100% success rate on the primary desensitization measure, versus 21% in the avoidance group, with 68.4% gaining sustained unresponsiveness. But the study was small, the population was highly specific, and mild reactions during dosing were common — so the findings don’t yet apply to routine practice or to people with more severe allergies.

Where this fits in the evidence

This is among the first studies we've indexed on peanut butter for Improved Peanut Tolerance — treat it as an early signal until more research accumulates.

The study

Peanut Oral Immunotherapy in Children with High-Threshold Peanut Allergy.

Randomized Controlled Trial (RCT)
n = 73
2025-02-25
NEJM evidence

More on peanut butter More on Improved Peanut Tolerance

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.